Shai Rubnov

Title: Shai Rubnov: Innovator in Long-Acting Pharmaceutical Compositions

Introduction

Shai Rubnov, based in Tel Aviv, Israel, is a prominent inventor with an impressive portfolio of 23 patents. His work focuses primarily on advancements in pharmaceutical compositions, contributing significantly to the field of medicine, particularly in the treatment of conditions such as multiple sclerosis.

Latest Patents

Rubnov's recent innovations include a patent on "Depot systems comprising glatiramer or pharmacologically acceptable salt thereof." This invention presents long-acting parenteral pharmaceutical compositions that incorporate a therapeutically effective amount of glatiramer acetate. The composition is designed for administration via subcutaneous or intramuscular routes, providing a medically acceptable option for patients in need.

Another notable patent is for a "Process for preparing microparticles containing glatiramer acetate." This invention outlines an improved method for producing microparticles with minimal residual organic solvents, particularly dichloromethane. The microparticles are intended for incorporation into long-acting pharmaceutical formulations suitable for treating multiple sclerosis through subcutaneous or intramuscular implantation or injection.

Career Highlights

Shai Rubnov works at Mapi Pharma Ltd., a company dedicated to developing innovative pharmaceutical solutions. His extensive experience in the field has led to numerous patents that enhance the therapeutic delivery of medications, showcasing his dedication to advancing healthcare options for patients.

Collaborations

Throughout his career, Rubnov has collaborated with talented professionals, including Ehud Marom and Michael Mizhiritskii. These partnerships have fostered an environment of innovation, allowing for the sharing of ideas and expertise that further push the boundaries of pharmaceutical research and development.

Conclusion

Shai Rubnov stands out as a key figure in the realm of pharmaceutical inventions. His commitment to developing long-acting formulations and improving drug delivery mechanisms is not only recognized through his numerous patents but also through the collaborative efforts with his esteemed colleagues. As he continues to innovate at Mapi Pharma Ltd., the healthcare industry eagerly anticipates the impact of his contributions on patient care.